Home/Filings/4/0001181431-13-019218
4//SEC Filing

Xiao Xiao-Yi 4

Accession 0001181431-13-019218

CIK 0001373707other

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 8:05 PM ET

Size

6.7 KB

Accession

0001181431-13-019218

Insider Transaction Report

Form 4
Period: 2013-03-25
Xiao Xiao-Yi
10% Owner
Transactions
  • Conversion

    Common Stock

    2013-03-25+4139,033 total
  • Conversion

    Series B Convertible

    2013-03-2512,0000 total
    Common Stock (413 underlying)
Footnotes (2)
  • [F1]The Series A-1, Series A-2, Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-29 basis upon the closing of the issuer's initial public offering without payment of consideration.
  • [F2]Not Applicable

Issuer

TETRAPHASE PHARMACEUTICALS INC

CIK 0001373707

Entity typeother

Related Parties

1
  • filerCIK 0001572245

Filing Metadata

Form type
4
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 8:05 PM ET
Size
6.7 KB